RN, Per Diem

Employment Type
Regular Part-Time
Requisition number
1900
Department
Clinical Research Center
Location : City
Seattle

Overview

The Clinical Research Center (CRC) is an outpatient, hospital-based clinic which provides nursing services for pediatric and adult participants enrolled in research studies, with an emphasis on autoimmune diseases (particularly Type 1 Diabetes), and immune therapies. The Registered Nurse supports and supplements regular staff during high census days and in other special circumstances, by providing various nursing services including: 

  • Starting IVs
  • Infusing investigational agents
  • Performing blood draws
  • Checking vital signs
  • Monitoring for adverse events
  • Other required nursing support to the research staff

The Per Diem Research Nurse will cover primarily day shift hours, though evening and night shifts may periodically be offered.  Due to the nature of scheduling on the CRC, the available shifts offered to the Per Diem pool often vary substantially from one month to the next. The usual operating times of the CRC are 7:30 am to 4:00 pm, Monday through Friday. 

Due to the nature of scheduling on the CRC, the available shifts offered to the Per Diem pool often vary substantially from one month to the next. Flexibility and availability are key qualities on the Per Diem RN team.

Responsibilities

  • Provides nursing services for pediatric and adult participants
  • Administers study drugs (IV, IM, SubQ, and PO) including biotherapy administration and monitoring
  • Provides back-up phlebotomy to medical assistants for participants with difficult veins (including pediatric blood draws)
  • Maintains compliance with Good Clinical Practice (GCP), Food and Drug Administration (FDA), International Conference on Harmonization (ICH), Health Insurance Portability and Accounting Act (HIPAA), and institutional policies and procedures.

Qualifications

  • Current license to practice as a Registered Nurse in Washington State
  • Two years of professional nursing experience in a high acuity patient setting
  • BLS certification required, ACLS and PALS highly desirable
  • Excellent IV and time management skills
  • Pediatric and/or research and/or Type One Diabetes experience preferred

Compensation

$41.44 to $65.88 per hour

Benefits

  • Paid sick leave
  • Subsidized bus pass

About Us

Benaroya Research Institute (BRI) has a bold mission: To predict, prevent, reverse and cure immune system diseases, from autoimmune disease to cancer to COVID-19. We examine the immune system in both health and disease to understand how disorders start and how to rebalance the immune system back to health. Equipped with innovative tools and robust biorepositories, our team chips away at the biggest mysteries behind these conditions to work toward our vision of a healthy immune system for everyone. BRI is a world-renowned independent nonprofit research institute affiliated with Virginia Mason Franciscan Health and based in Seattle. We collaborate with clinicians to accelerate the path from innovative lab discoveries to life-changing patient care.

 

At BRI, each role is valued and an important contributor to our vision and mission. BRI is committed to a safe, caring and diverse workplace; as well as to taking action to further our commitments to foster inclusion, equity and belonging so employees feel comfortable bringing their full selves to work. Consider making a difference by joining our team. Because together, we are powering possibility.

 

To learn more, visit benaroyaresearch.org and connect with us on Facebook, Instagram, Threads,  LinkedIn, X and YouTube.

 

 

All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, citizenship, disability or protected veteran status. If you need assistance completing the application process, please contact Human Resources at 206-342-6972 or email jobs@benaroyaresearch.org.

#LI-DNP

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed